Deconvoluting Kinase Inhibitor Induced Cardiotoxicity

Many drugs designed to inhibit kinases have their clinical utility limited by cardiotoxicity-related label warnings or prescribing restrictions. While this liability is widely recognized, designing safer kinase inhibitors (KI) requires knowledge of the causative kinase(s). Efforts to unravel the kin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Toxicol Sci
Hlavní autoři: Lamore, Sarah D., Ahlberg, Ernst, Boyer, Scott, Lamb, Michelle L., Hortigon-Vinagre, Maria P., Rodriguez, Victor, Smith, Godfrey L., Sagemark, Johanna, Carlsson, Lars, Bates, Stephanie M., Choy, Allison L., Stålring, Jonna, Scott, Clay W., Peters, Matthew F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Kinase Inhibitors and Cardiotoxicity
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837613/
https://ncbi.nlm.nih.gov/pubmed/28453775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/toxsci/kfx082
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky